← Catalog
Retatrutide 40mg research vial, Sacred Peptides

Metabolic

Retatrutide 40mg

Triple agonist: GLP-1 / GIP / glucagon

Fill
40 mg / vial
Pack
1 vial · 40 mg total
Purity
≥99%
Choose pack size
Price
$190
In stock
Secure checkout COA with every vial Ships from Canada

Dispatched from Victoria, British Columbia to all 13 provinces and territories. Lyophilized peptides are stable at ambient temperature for the length of a domestic shipment.

Retatrutide 40mg
$190

Overview

A synthetic triple incretin receptor agonist, supplied at a 40 mg fill. Supplied lyophilized for in-vitro study of GLP-1, GIP and glucagon receptor signalling.

Receptor pharmacology

Simultaneous agonism at the GLP-1, GIP and glucagon receptors. The added glucagon receptor activity is what separates retatrutide from GLP-1-only and GLP-1 / GIP dual agonists in receptor-binding and signalling assays.

Laboratory handling

Preparation
Reconstitute for in-vitro use
Half-life
~6 days
Per vial
40 mg / vial · 1 vial · 40 mg total
Purity
≥99%

Research use disclaimer

Sacred Peptides does not provide dosing recommendations for human use. Retatrutide 40mg is supplied for in-vitro laboratory research only. Any concentration ranges referenced on this page or in cited studies describe the parameters used in that research and are not instructions.

  • Not a drug. Not approved by Health Canada or the FDA for human use.
  • Not intended to diagnose, treat, cure, or prevent any disease.
  • Not for use in humans, pregnant or nursing individuals, or animals outside a controlled research setting.
  • Handling, storage, and disposal are the responsibility of a qualified researcher.